Bought the ticket, hasn't taken the ride: the company has already paid for its next stage and is now waiting to be paid
The model's full reasoning — Q4 2021 call → NOWe need to determine if management describes a situation where the company has already spent or committed resources for a stage of business that has not yet been paid back, with the return still outstanding and treated as a matter of time. The transcript discusses commercial performance, clinical development, and financial results. Key points: HETLIOZ and Fanapt sales, payer challenges, SMS launch, tradipitant gastroparesis study results, and financial guidance. The question asks about a specific phenomenon: company has already paid for something, but the return is not yet in, and management expects it to come in time. Look for any such description. Management discusses R&D expenses, late-stage programs, and commercial launches. For example, they mention "we are in the early stages of commercial launch for HETLIOZ in SMS" and "we expect both R&D and SG&A operating expenses to rise in 2022 as compared to 2021 spending levels." But that's future spending. They also mention "we have made significant progress in the past quarter on beginning to resolve payer challenges" but that's not a payment. The tradipitant study is completed, but that's a clinical trial, not a business stage with revenue. The question is about a stage of business where they've spent to reach a larger operation, but revenue hasn't arrived. For example, they launched HETLIOZ for SMS, and they have more than 50 patients on treatment, but that's early. They also have a genetics platform discovery. But is there a clear statement that they've already spent money and the return is outstanding? They mention "we are working closely with advocacy organizations in direct-to-consumer campaigns" but that's ongoing. The financial guidance for 2022 includes net product sales between $240M and $280M, and they expect cash to grow. They also mention "we expect first quarter 2022 HETLIOZ revenue to be impacted by annual Medicare manufacturer contribution" etc. That's not a payment for future return. The key is whether management describes a situation where they've already invested in something that will pay off later. For instance, they have a Phase III study for Fanapt bipolar disorder that is over 50% enrolled, but that's a clinical trial, not a business stage. The question is about "a stage of business" - like building a plant, entering a market, hiring sales force, etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
PRIM · Q2 2018 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the revenue from that hasn't arrived yet. YES The transcript shows management describing the Willbros acquisition as a completed outlay: closed June 1, $165 million total paid ($38.4 million cash for shares + $123.2 million debt settlement + $3.1 million fees), net cash $111 million, funded by revolver, then refinanced 220 million term loan. This is treated as already done, not planned. The return is still largely outstanding: only one month of Willbros operations reported ($61 million revenue, $6.8 million gross profit, $2.9 million operating income in June), merger-related expenses $7.
PSX · Q4 2016 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the returns haven't come yet, and they expect them soon as a matter of time. YES Management describes the U.S. Gulf Coast Petrochemicals Project as already substantially paid for: capital spending is “reduced following the completion of the project” and “down significantly” compared with last year, with roughly $1 billion of CapEx no longer available for distribution.
TGI · Q2 2017 → YESThe question is about whether management describes having already spent money or resources for a larger operation that hasn't paid back yet. YES The transcript shows management describing a clear situation matching all three criteria. On slide 13, they report "$126 million" of year-to-date investments in development programs as a completed cash outflow ("used $126 million"), with incremental customer financing providing $100 million offset.